Tyche Wealth Partners LLC Invests $302,000 in The Clorox Company (NYSE:CLX)

Tyche Wealth Partners LLC bought a new position in shares of The Clorox Company (NYSE:CLX) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 2,117 shares of the company’s stock, valued at approximately $302,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. American Century Companies Inc. increased its position in Clorox by 18.0% in the 1st quarter. American Century Companies Inc. now owns 8,320 shares of the company’s stock valued at $1,157,000 after acquiring an additional 1,269 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in Clorox by 6.8% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 16,465 shares of the company’s stock valued at $2,289,000 after acquiring an additional 1,044 shares during the period. Cibc World Market Inc. increased its position in Clorox by 276.6% in the 1st quarter. Cibc World Market Inc. now owns 9,318 shares of the company’s stock valued at $1,295,000 after acquiring an additional 6,844 shares during the period. Dimensional Fund Advisors LP increased its position in Clorox by 0.8% in the 1st quarter. Dimensional Fund Advisors LP now owns 683,818 shares of the company’s stock valued at $95,073,000 after acquiring an additional 5,145 shares during the period. Finally, Blair William & Co. IL increased its position in Clorox by 81.1% in the 1st quarter. Blair William & Co. IL now owns 24,525 shares of the company’s stock valued at $3,410,000 after acquiring an additional 10,981 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

CLX stock opened at $142.29 on Thursday. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $178.21. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. The stock’s 50 day moving average price is $150.40 and its 200 day moving average price is $141.69. The firm has a market cap of $17.66 billion, a P/E ratio of 225.86, a PEG ratio of 2.22 and a beta of 0.43.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the company earned $0.98 EPS. Clorox’s revenue was up 16.0% on a year-over-year basis. On average, sell-side analysts expect that The Clorox Company will post 5.52 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a yield of 3.37%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s payout ratio is currently 761.92%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. Morgan Stanley reaffirmed an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. Barclays lowered their price objective on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a report on Wednesday, April 10th. The Goldman Sachs Group assumed coverage on Clorox in a report on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective on the stock. UBS Group lifted their price objective on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. Finally, Citigroup lowered their price objective on Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a report on Tuesday. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $148.63.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.